Petrovax Pharm LLC has received a European patent for the original medicine product Longidaza®, which is valid in the UK, Germany, France, Switzerland, Ireland,...
R-Pharm Group, the Russian Direct Investment Fund (RDIF) and AstraZeneca announce preliminary virus neutralizing activity results of combined use of the AstraZeneca vaccine (developed...
New results for Phase III study of BCD-021, a bevacizumab biosimilar, were presented as a poster at the European Society for Medical Oncology (ESMO)...
On September 21, Biokhimik JSC (part of the Promomed Group) and the Ministry of Economy, Trade and Entrepreneurship of Mordovia signed an agreement on...
Remdesivir (trade name: Remdeform, MA No. ЛП-006505 of October 14, 2020г) has been included into all in-hospital treatment regimens in the 12th version of...
Areplivir, included in the guidelines of the Ministry of Health of Russia for the treatment of COVID-19, received marketing authorization in Uzbekistan.
On August 4,...